GMEC/Pfizer Rare Disease Collaboration: First Projects Signed

GMEC is pleased to announce the signing of the first collaborative research projects to be launched under theGMEC/Pfizer Rare Diseases agreement which was announced in 2014.

The University of Oxford and Pfizer have agreed three funded research projects in the fields of haematology and neuromuscular disorders. For additional information click here to see the announcement by University of Oxford.